Economy Summit

March 13, 2013
Washington, DC

The “Great Recession” has prompted professors, policymakers, and pundits to take positions on the health of the U.S. economy and the cause of the crisis. Some experts believe that we are on a road to recovery, but a major question remains to be resolved: debt. While many have focused on the negative effects of our national debt, evidence shows that private debt—held by consumers and private businesses alike—may undermine our economy to an even greater degree.

With keynote speaker Paul Volcker, former Chairman of the Federal Reserve, The Atlantic's Second Annual Economy Summit examined topics like the declining value of the dollar, the merits of deleveraging the U.S. economy through targeted policies, the possibility of new “bubbles” forming in healthcare, education, and other industries, and the road to recovery. 

For a transcript of James Bennet's interview with Gene Sperling, CLICK HERE

For a transcript of Paul Volcker's keynote presentation, CLICK HERE

For a transcript of John Hoeven being interviewed by Steve Clemons, CLICK HERE

For a transcript of Grover Norquist being interviewed by Steve Clemons, CLICK HERE

 
 

Presented by

Atlantic Live

Speakers

Underwriters

Presenting Level

Supporting Level

Upcoming Events

  • Washington Ideas
    • September 26 – 28, 2017
    • Washington, DC

    For its ninth year, the Washington Ideas Forum will convene the nation's leaders, from politics and government to business and culture for two days of idea sharing and thought provoking conversation.

  • Technology

    Cracking the Code: The Next Generation of Women in STEM
    • September 29, 2017
    • Boston

    In this Atlantic summit, we will bring together the leading educators, thought leaders, students and creators re-thinking from the ground up what it means to raise and become a woman in STEM.

  • Health Care

    At What Cost?
    An Atlantic Forum on Prescription Drugs
    • October 3, 2017
    • Washington, DC

    The Atlantic will convene top health policy thinkers and practitioners to explore how to foster drug innovation while controlling cost with new approaches like value-based programs on the horizon.

See All Upcoming Events